JP2021516668A5 - - Google Patents
Info
- Publication number
- JP2021516668A5 JP2021516668A5 JP2020542989A JP2020542989A JP2021516668A5 JP 2021516668 A5 JP2021516668 A5 JP 2021516668A5 JP 2020542989 A JP2020542989 A JP 2020542989A JP 2020542989 A JP2020542989 A JP 2020542989A JP 2021516668 A5 JP2021516668 A5 JP 2021516668A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- slamf6
- cells
- cell population
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862629129P | 2018-02-12 | 2018-02-12 | |
| US62/629,129 | 2018-02-12 | ||
| PCT/IL2019/050163 WO2019155474A1 (en) | 2018-02-12 | 2019-02-11 | Modulation of slamf6 splice variants for cancer therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021516668A JP2021516668A (ja) | 2021-07-08 |
| JP2021516668A5 true JP2021516668A5 (https=) | 2022-02-21 |
| JP7458318B2 JP7458318B2 (ja) | 2024-03-29 |
Family
ID=67548888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542989A Active JP7458318B2 (ja) | 2018-02-12 | 2019-02-11 | 癌治療のためのｓｌａｍｆ６スプライスバリアントの調節 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11834487B2 (https=) |
| EP (1) | EP3752252A4 (https=) |
| JP (1) | JP7458318B2 (https=) |
| IL (1) | IL276117B1 (https=) |
| WO (1) | WO2019155474A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL267614A (en) | 2019-06-24 | 2019-09-26 | Lotem Michal | Nucleic acids to modulate SLAMF6 isoforms |
| CN117867107A (zh) * | 2023-11-24 | 2024-04-12 | 南通大学附属医院 | 一种构建肠癌诊断和预后相关的甲基化位点的诊断模型方法及其诊断标志物slamf6 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US7479269B2 (en) | 1988-11-23 | 2009-01-20 | Genetics Institute, Llc | Methods for selectively enriching TH1 and TH2 cells |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5719867A (en) | 1995-06-30 | 1998-02-17 | Scientific-Atlanta, Inc. | Plural telephony channel baseband signal demodulator for a broadband communications system |
| US7138243B2 (en) | 2001-07-19 | 2006-11-21 | Innate Pharma, S.A. | NTB-A, a surface molecule involved in natural killer cells activity |
| MXPA04001986A (es) | 2001-08-29 | 2004-06-07 | Genentech Inc | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. |
| JP2005206478A (ja) | 2004-01-20 | 2005-08-04 | Kirin Brewery Co Ltd | 樹状細胞膜分子−ＩｇＦｃ融合ポリペプチドまたはそれに対する抗体を含む医薬組成物 |
| US7592313B2 (en) | 2004-05-17 | 2009-09-22 | Board Of Trustees Of The University Of Illinois | Method of stimulating proliferation of regulatory T cells in a diabetic mammal |
| EP1642905B1 (en) | 2004-10-02 | 2009-01-21 | Immatics Biotechnologies GmbH | Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| CA2604844A1 (en) | 2005-04-07 | 2006-10-19 | Novartis Vaccines And Diagnostics, Inc. | Cancer-related genes |
| EP1916302A4 (en) | 2005-08-17 | 2009-10-21 | Takara Bio Inc | PROCESS FOR THE PRODUCTION OF LYMPHOCYTES |
| EP1777523A1 (en) | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| TW200823237A (en) | 2006-08-28 | 2008-06-01 | Nuvelo Inc | Antibodies to NTB-A |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| WO2014161509A1 (en) | 2013-04-05 | 2014-10-09 | The University Of Hong Kong | Novel pd1 isoforms, and uses thereof for potentiating immune responses |
| EP3087101B1 (en) | 2013-12-20 | 2024-06-05 | Novartis AG | Regulatable chimeric antigen receptor |
| WO2015104711A1 (en) | 2014-01-09 | 2015-07-16 | Hadasit Medical Research Services And Development Ltd. | Improved cell compositions and methods for cancer therapy |
| HRP20211058T8 (hr) | 2015-07-29 | 2021-11-26 | Novartis Ag | Kombinirane terapije koje sadrže molekule antitijela protiv lag-3 |
| WO2017075478A2 (en) | 2015-10-28 | 2017-05-04 | The Broad Institute Inc. | Compositions and methods for evaluating and modulating immune responses by use of immune cell gene signatures |
| NL2017267B1 (en) | 2016-07-29 | 2018-02-01 | Aduro Biotech Holdings Europe B V | Anti-pd-1 antibodies |
| WO2018049025A2 (en) | 2016-09-07 | 2018-03-15 | The Broad Institute Inc. | Compositions and methods for evaluating and modulating immune responses |
| IL267614A (en) | 2019-06-24 | 2019-09-26 | Lotem Michal | Nucleic acids to modulate SLAMF6 isoforms |
-
2019
- 2019-02-11 JP JP2020542989A patent/JP7458318B2/ja active Active
- 2019-02-11 US US16/968,967 patent/US11834487B2/en active Active
- 2019-02-11 WO PCT/IL2019/050163 patent/WO2019155474A1/en not_active Ceased
- 2019-02-11 EP EP19751265.0A patent/EP3752252A4/en active Pending
- 2019-02-11 IL IL276117A patent/IL276117B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Samadi et al. | Therapeutic applications of mesenchymal stem cells:: a comprehensive review | |
| Fan et al. | Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord | |
| Golchin et al. | The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review | |
| Fan et al. | Directing induced pluripotent stem cell derived neural stem cell fate with a three-dimensional biomimetic hydrogel for spinal cord injury repair | |
| Chalisserry et al. | Therapeutic potential of dental stem cells | |
| Liu et al. | Concise reviews: Characteristics and potential applications of human dental tissue-derived mesenchymal stem cells | |
| Vawda et al. | Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives | |
| Nomura et al. | Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection | |
| Trotzier et al. | Fat graft retention: adipose tissue, adipose-derived stem cells, and aging | |
| ES2927461T3 (es) | Células madre mesenquimatosas derivadas de tejido perinatal: método de preparación y utilizaciones de las mismas | |
| Das et al. | Adult mesenchymal stem cells and their potency in the cell-based therapy | |
| Gugjoo et al. | Mesenchymal stem cell research in veterinary medicine | |
| Conese et al. | Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases | |
| IL259120A (en) | Her2-targeted antigen chimeric receptors2 | |
| US20120269774A1 (en) | Allogeneic stem cell transplants in non-conditioned recipients | |
| ES2673861T3 (es) | Método novedoso para tratar el daño a la médula espinal utilizando el fragmento de hmgb1 | |
| Farkhad et al. | How similar are human mesenchymal stem cells derived from different origins? A review of comparative studies | |
| CN103687946A (zh) | 用于诱导组织再生的肽及其应用 | |
| CA3139514A1 (en) | Therapeutically active cells and exosomes | |
| JP2022522231A5 (https=) | ||
| WO2006113881A2 (en) | Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood | |
| CN111979187A (zh) | 一种抗人间充质干细胞衰老及增强其干性特征的方法 | |
| CN111542597A (zh) | 用于扩增造血干细胞和祖细胞的组合物和方法 | |
| AR037038A1 (es) | Una composicion y metodo para alterar la masa corporal magra y las propiedades oseas en un sujeto | |
| JP2021516668A5 (https=) |